Calithera Biosciences' IPO

Calithera Biosciences raised a round of funding on October 02, 2014. Investors include Public.

Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. The comp…

Articles about Calithera Biosciences' IPO: